Hyperrab
Generic name:rabies immune globulin (human)
Dosage form: injection, solution
Drug class:Immune globulins
Medically reviewed by Drugs.com. Last updated on Apr 1, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Hyperrab
Hyperrab is a human rabies immune globulin indicated for postexposure prophylaxis, along with rabies vaccine, for all persons suspected of exposure to rabies.
Limitation of Use
Persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer should receive only vaccine.(1-3)
For unvaccinated persons, the combination of Hyperrab and vaccine is recommended for both bite and nonbite exposures regardless of the time interval between exposure and initiation of postexposure prophylaxis.(1-3)
Beyond 7 days (after the first vaccine dose), Hyperrab is not indicated since an antibody response to vaccine is presumed to have occurred.
Hyperrab Dosage and Administration
For infiltration and intramuscular use only.
The strength of Hyperrab is 300 IU/mL.
Dose
Use Hyperrab in combination with rabies vaccine series to be effective. Do not use Hyperrab alone for prevention.
Administer Hyperrab within 7 days after the first dose of rabies vaccine.
| Vaccination Status |
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram
|
